AbbVie Wins U.S. Antitrust Nod for Botox Maker Allergan

(Bloomberg) -- AbbVie Inc. won U.S. antitrust approval for its acquisition of Botox maker Allergan Plc, clearing the last hurdle from competition regulators to the $63 billion deal.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.